Steve is currently the CIO of the Pharma Division of Roche. He will soon lead all business informatics for the Roche Group, including pharma and diagnostics. He is enabling the digital transformation across Roche, covering topics from discovery research to development and commercialisation.
Avril England is the general manager of Veeva Vault, a fast-growing cloud software platform and suite of applications to manage content, data, and business processes for life sciences and other regulated industries. Under Avril’s leadership, Veeva Vault has grown to represent 40% of Veeva revenues. Avril has more than 20 years of experience building and scaling product teams, including 15 years at innovative software-as-a-service companies. She was a key contributor in two successful IPOs and played leadership roles at world-class organizations including Oracle’s PeopleSoft, Cisco’s WebEx, and IBM’s DemandTec. Avril holds a bachelor of commerce honors degree from Queen’s University in Ontario, Canada, and has received numerous professional and academic awards.
As president of Veeva Europe, Chris is responsible for growing the business in the region. A 27-year veteran of the life sciences industry, Chris started his career at ICI Pharmaceuticals (now AstraZeneca). Chris then joined a start-up called Kinesis, building a team delivering document management solutions for pharmaceutical companies. Through a series of mergers and acquisitions, Kinesis ultimately became PwC; Chris made partner with PwC in 2001. Chris went on to run both European and US (West Coast) life sciences business for IBM before leading the IBM global life sciences consulting Business Analytics and Optimization unit. Most recently, Chris was the lead partner for life sciences for Europe, the Middle East, and Africa at EY. Chris holds a bachelor of science degree in information technology from the University of Salford.
As Vice President of Vault Development Cloud at Veeva, Jim leads a global team responsible for customer engagement, market adoption, and strategic alliances. For the last 20 years, Jim has held a variety of senior positions in life sciences technology and consulting, where he has led software delivery and sales efforts in clinical operations, regulatory, clinical data standards, and content management.
Senior Director, Business Systems R&D
Salman has over 14 years of experience in the biotech/pharma industry, leading digital transformation initiatives, drug development, and product launch readiness programs. He currently leads digital optimization and transformation efforts for R&D at argenx. Previously, Salman held various leadership roles in UCB Pharma and Baxter. He has a Master’s degree in Business & Management and a Bachelor’s degree in Engineering. Salman also volunteers for the CureforU network, which aims to improve outcomes for patients with rare or complex diseases.
Business Lead, Vault CDMS Project
Leonie has over 25 years of experience leading complex and high-impact transformational technology projects within clinical data management. Her projects frequently involve stakeholders from CRA/monitoring, clinical operations, safety case management, and IT/tech strategy. Currently, she is leading the implementation of Vault CDMS as an enterprise platform across GSK, looking at automation opportunities to improve efficiency, quality, and time to delivery.
Michel is a service-oriented leader of transformational change programs with experience across small and large pharmaceuticals, vaccines, biotechnology, and outsourcing companies. She has expertise in clinical study planning and operations, patient safety, biostatistics, and regulatory operations. In her current role, she is accountable for a suite of priority projects to create the interoperable ecosystem to progress late-stage pipeline assets, which reaches all functional development areas.
Idorsia Pharmaceuticals Ltd.
Senior Director, Team Leader Clinical & Quality Systems
Simone is responsible for the implementation of Idorsia’s clinical & quality systems landscape and is the system owner of Veeva Vault (RIM, Clinical, Quality, Contract Management). Simone holds a degree in biology from the University of Freiburg, Germany, and has over 10 years of consulting experience in pharmaceutical R&D, strategy development, process optimization, and restructuring programs. In 2011, Simone joined Actelion Pharmaceuticals as eClinical program & change manager. She transferred to Idorsia Pharmaceuticals when the company was founded as a spin-off during the acquisition of Actelion by Johnson & Johnson in June 2017.
Pilar is a medical doctor with a Ph.D. in biochemistry and molecular biology with over twenty years of experience in the pharmaceutical industry. She has dedicated fifteen years to research in both academia (Karolinska Institute in Stockholm) and industry (Novo Nordisk in Copenhagen) working in metabolic diseases and oncology. With seventeen years of experience in multiple roles in pharmacovigilance, Pilar currently leads global safety at LEO Pharma.
Head of Regulatory Affairs Systems and Analytics
Helen is the head of RA systems and analytics at Mundipharma working with the team implementing Vault RIM. Previously, Helen was a CMC marketed product lead. Before joining Mundipharma, she worked at Kinapse as program director and program lead where she managed outsourcing programs for post-approval activities.
Poul Henning Poulsen
Corporate VP, Quality Systems
Poul is responsible for developing and maintaining the quality management system at Novo Nordisk, focusing on harmonising and standardising the company’s quality processes. He has over 30 years of leadership experience at Novo Nordisk in quality assurance, manufacturing, development, regulatory affairs, and supply chain. Poul holds a doctorate in veterinary medicine, specialising in microbiology.
As a Global Director for Enterprise Application Management Akos is responsible for Veeva’s post-implementation services strategy for the Development Cloud. He works with customers and Veeva teams to design methodologies and offerings that support adoption of Veeva’s rapid product innovation and a constantly changing business requirement landscape.
Since joining Veeva in 2014, Akos has been working in multiple roles including implementations, managed services and various leadership positions.
As Vice President of the Vault Quality product suite, Mike is responsible for product strategy, customer engagement, and business development. Previously, he served as vice president of product management and strategy for Sparta Systems, where he was instrumental in the company’s rapid growth, driving product development, vertical market strategy, and strategic partner alliances. Educated at Rutgers, he holds a bachelor’s degree in marketing and an MBA in strategy and global business.
As Director of EU R&D & Quality Customer Success, Neelam leads a team responsible for ongoing education on product releases, functionality, industry best practices and to help customers maximize on their Veeva investment(s). For the last 20 years, Neelam has held a variety of positions in life sciences technology and consulting, a successful manager in systems development, technology implementation, and people management on EDMS systems across Quality, Regulatory, Clinical and Safety (PV).
Richard is VP of strategy for Vault CDMS, and a 25-year veteran in life sciences. Richard is responsible for defining strategy and direction for Vault CDMS, especially concerning clinical data management. Richard brings Veeva customers both keen executive vision and proven operational experience in data management, eClinical solutions, and advanced clinical strategies.
Senior Director, Vault Safety Strategy EU
Sharmila Sabaratnam is a Senior Director at Veeva Systems responsible for EU SMB Vault Safety Strategy helping customers to transform their business through unified safety platform adoption. Physiologist by training with research experience within oncology and arthritis. She has 15+ years’ experience within safety, previously leading safety and regulatory advisory services for Top-25 and Top-100 companies within Ernst & Young and Navitas. Her experience includes operating model design and safety strategy, PV automation, benefit-risk management and performance benchmarking. As a senior leader within the NHS, led R&D clinical operations with a large oncology clinical trials portfolio, including the Biomedical Centre for Translational Research.